Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

To main content To sitemap To news Check availability details

Commercial partnership development for RespiHeart in India

Reference number
Coordinator RespiHeart AB
Funding from Vinnova SEK 100 650
Project duration October 2024 - March 2025
Status Ongoing
Venture Medtech4Health: Competence Enhancement in SME
Call Medtech4Health: Competence Enhancement in Small Businesses 2024

Purpose and goal

The project aims to, with the support of Business Sweden and their team in India, identify, qualify and introduce RespiHeart to potential medical technology companies. The goal is to establish a partnership with an Indian medical technology company for product development and commercialization of RespiHeart in India.

Expected effects and result

Short-term effects of the competence support concern the possibility of implementing and exposing the RespiHeart method in relation to potential partners in the Indian market. In the longer term, the expected result is a collaboration that will lead to the first commercial product based on RespiHeart´s IP.

Planned approach and implementation

The project is carried out in three main stages: 1. Planning and preparation (Nov) - specification of IP, offer and definition of criteria and characteristics of potential partner companies 2. Identification and qualification of partners (Dec-Jan) 3. Implementation of meetings and follow-up (Feb-Mar)

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 31 October 2024

Reference number 2024-02097